Study Details | Efficacy, safety, and pharmacokinetics of vericiguat in pediatric participants with heart failure due to left ventricular systolic dysfunction |
Protocol Number | 036-00 |
Phase | II/III |
Therapeutic Area | Heart failure |
Subject Types | With Medical Condition |
Indication | HF due to systemic LV Systolic Dysfunction |
Principal Investigator | Dr Chen Ching Kit |
Investigator Product / Device | MK-1242 |
Sponsor |
Merck Sharp & Dohme LLC |